You can:
Name | Gastrin/cholecystokinin type B receptor |
---|---|
Species | Homo sapiens (Human) |
Gene | CCKBR |
Synonym | CCK-B receptor CCK-B receptor {ECO:0000303|PubMed:8415658} CCK-B/gastrin receptor CCK-BR gastrin/cholecystokinin type B receptor [ Show all ] |
Disease | Diagnostic imaging Duodenal ulcers Gastroesophageal reflux disease Gastrointestinal disease Intestine cancer [ Show all ] |
Length | 447 |
Amino acid sequence | MELLKLNRSVQGTGPGPGASLCRPGAPLLNSSSVGNLSCEPPRIRGAGTRELELAIRITLYAVIFLMSVGGNMLIIVVLGLSRRLRTVTNAFLLSLAVSDLLLAVACMPFTLLPNLMGTFIFGTVICKAVSYLMGVSVSVSTLSLVAIALERYSAICRPLQARVWQTRSHAARVIVATWLLSGLLMVPYPVYTVVQPVGPRVLQCVHRWPSARVRQTWSVLLLLLLFFIPGVVMAVAYGLISRELYLGLRFDGDSDSDSQSRVRNQGGLPGAVHQNGRCRPETGAVGEDSDGCYVQLPRSRPALELTALTAPGPGSGSRPTQAKLLAKKRVVRMLLVIVVLFFLCWLPVYSANTWRAFDGPGAHRALSGAPISFIHLLSYASACVNPLVYCFMHRRFRQACLETCARCCPRPPRARPRALPDEDPPTPSIASLSRLSYTTISTLGPG |
UniProt | P32239 |
Protein Data Bank | N/A |
GPCR-HGmod model | P32239 |
3D structure model | This predicted structure model is from GPCR-EXP P32239. |
BioLiP | N/A |
Therapeutic Target Database | T05849 |
ChEMBL | CHEMBL298 |
IUPHAR | 77 |
DrugBank | BE0001158 |
Name | Tyr-D-Phe-Gly-Trp-Nle-Asp-Phe-NH2 |
---|---|
Molecular formula | C50H59N9O10 |
IUPAC name | (3S)-3-[[(2S)-2-[[(2S)-2-[[2-[[(2R)-2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-3-phenylpropanoyl]amino]acetyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]hexanoyl]amino]-4-[[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-4-oxobutanoic acid |
Molecular weight | 946.075 |
Hydrogen bond acceptor | 11 |
Hydrogen bond donor | 11 |
XlogP | 0.8 |
Synonyms | BDBM21137 CHEMBL382051 (3S)-3-[(2S)-2-[(2S)-2-{2-[(2R)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-3-phenylpropanamido]acetamido}-3-(1H-indol-3-yl)propanamido]hexanamido]-3-{[(1S)-1-carbamoyl-2-phenylethyl]carbamoyl}propanoic acid CCK-Opioid Peptide, 7 D03EPA |
Inchi Key | DWHRPZRXNRDAQF-GEQJWKGNSA-N |
Inchi ID | InChI=1S/C50H59N9O10/c1-2-3-17-38(48(67)59-42(27-44(62)63)50(69)57-39(45(52)64)24-30-12-6-4-7-13-30)56-49(68)41(26-33-28-53-37-18-11-10-16-35(33)37)55-43(61)29-54-47(66)40(25-31-14-8-5-9-15-31)58-46(65)36(51)23-32-19-21-34(60)22-20-32/h4-16,18-22,28,36,38-42,53,60H,2-3,17,23-27,29,51H2,1H3,(H2,52,64)(H,54,66)(H,55,61)(H,56,68)(H,57,69)(H,58,65)(H,59,67)(H,62,63)/t36-,38-,39-,40+,41-,42-/m0/s1 |
PubChem CID | 11051303 |
ChEMBL | CHEMBL382051 |
IUPHAR | N/A |
BindingDB | 21137 |
DrugBank | N/A |
Structure | ![]() |
Lipinski's druglikeness | This ligand has more than 5 hydrogen bond donor. This ligand has more than 10 hydrogen bond acceptor. This ligand is heavier than 500 daltons. |
Parameter | Value | Reference | Database source |
---|---|---|---|
EC50 | 107.15 nM | PMID16686530 | ChEMBL |
EC50 | 110.0 nM | PMID16686530 | BindingDB,ChEMBL |
Emax | 9.5 % | PMID16686530 | ChEMBL |
IC50 | 25.7 nM | PMID16686530 | ChEMBL |
Ki | 26.0 nM | PMID16686530 | BindingDB,ChEMBL |
zhanglabzhanggroup.org | +65-6601-1241 | Computing 1, 13 Computing Drive, Singapore 117417